ABSTRACT
BACKGROUND: Surgery on primary tumor (SPT) has been a common treatment strategy for many types of cancer. AIMS: This study aimed to investigate whether SPT could be considered a treatment option for metastatic esophageal cancer and to identify the patient population that would benefit the most from SPT. METHODS: Data from 18 registration sites in the Surveillance, Epidemiology, and End Results Program database (SEER database) were analyzed to select patients with metastatic esophageal cancer. Multivariate Cox regression analysis was used to identify potential risk factors for pre-treatment survival. Variables with a p-value of less than 0.05 were used to construct a pre-treatment nomogram. A pre-surgery predictive model was then developed using the pre-surgery factors to score patients, called the "pre-surgery score". The optimal cut-off value for the "pre-surgery score" was determined using X-tile analysis, and patients were divided into high-risk and low-risk subsets. It was hypothesized that patients with a low "pre-surgery score" risk would benefit the most from SPT. RESULTS: A total of 3793 patients were included in the analysis. SPT was found to be an independent risk factor for the survival of metastatic esophageal cancer patients. Subgroup analyses showed that patients with liver or lung metastases derived more benefit from SPT compared to those with bone or brain metastases. A pre-treatment predictive model was constructed to estimate the survival rates at one, two, and three years, which showed good accuracy (C-index: 0.705 for the training set and 0.701 for the validation set). Patients with a "pre-surgery score" below 4.9 were considered to have a low mortality risk and benefitted from SPT (SPT vs. non-surgery: median overall survival (OS): 24 months vs. 4 months, HR = 0.386, 95% CI: 0.303-0.491, p < 0.001). CONCLUSION: This study demonstrated that SPT could improve the OS of patients with metastatic esophageal cancer. The pre-treatment scoring model developed in this study might be useful in identifying suitable candidates for SPT. The strengths of this study include the large patient sample size and rigorous statistical analyses. However, limitations should be noted due to the retrospective study design, and prospective studies are needed to validate the findings in the future.
Subject(s)
Esophageal Neoplasms , Nomograms , Humans , Neoplasm Staging , Retrospective Studies , Esophageal Neoplasms/surgery , Esophageal Neoplasms/pathology , Risk FactorsABSTRACT
A fully transportable laser heterodyne radiometer (LHR), involving a flexible polycrystalline mid-infrared (PIR) fiber-coupling system and operating around 8 µm, was characterized and optimized with the help of a calibrated high temperature blackbody source to simulate solar radiation. Compared to a mid-IR free-space sunlight coupling system, usually used in a current LHR, such a fiber-coupling system configuration makes the mid-infrared (MIR) LHR fully transportable. The noise sources, heterodyne signal, and SNR of the MIR LHR were analyzed, and the optimum operating local oscillator (LO) photocurrent was experimentally obtained. The spectroscopic performance of the MIR LHR was finally evaluated. This work demonstrated that the developed fully transportable MIR LHR could be used for ground-based atmospheric sounding measurements of multiple trace gases in the atmospheric column. In addition, it also has high potential for applications on spacecraft or on an airborne platform.
Subject(s)
Lasers , Radiometry , Spectrum Analysis/methods , Gases , LightABSTRACT
BACKGROUND: The rapidly increasing morbidity and the poor prognosis making the colon adenocarcinoma not only common but also highly malignant. On the other hand, immunotherapy emerges as a therapeutic modality of colon cancer recently. In this study, we developed a prognostic risk model that is based on immune genes, which could predict the overall survival (OS) of patients with colon adenocarcinoma. METHODS: The Cancer Genome Atlas (TCGA) database was used to download both transcriptomic and clinical data, and the ImmPort database was used to obtain immune genes. The least absolute shrinkage and selection operator (LASSO)-Cox regression was adopted to further select the key genes with prognostic value. Then the key genes were inputted into stepwise regression to calculated each patient's immune-related risk score (immune score). Survival, survminer packages and bilateral tests in R language were adopted to determine the optimal cut-off value (cut-off value) for the risk score. This threshold divides patients into immune-score high-risk and low-risk groups. The differences in the levels of infiltrating immune cells and stromal cells in the high and low immune risk groups were then calculated and compared by the CIBERSORT algorithm. RESULTS: According to our results, a prognostic risk model was constructed based upon 26 immune-related genes. High immune score was shown to be a poor prognostic factor for colon adenocarcinoma patients, such as overall survival, progress free survival for different therapies, and tumor stages. High immune score was also associated with the abundance of CD4+ T cells and CD8+ T cells. In addition, the high immune score group, the expression levels of LMTK3, LAG3 and PD-L1 were higher than those in the low score group. CONCLUSION: We developed a 26-immune gene model of colon adenocarcinoma to predict patient's survival. This model might be used in clinical practice as a prognostic instrument for patients diagnosed with colon adenocarcinoma.
Subject(s)
Adenocarcinoma , Colonic Neoplasms , Humans , Algorithms , CD8-Positive T-Lymphocytes , Databases, Factual , Membrane Proteins , Protein Serine-Threonine KinasesABSTRACT
Research on possible topological superconductivity has grown rapidly over the past several years, from fundamental studies to the development of next generation technologies. Recently, it has been reported that the SrxBi2Se3 exhibits superconductivity with topological surface state, making this compound a promising candidate for investigating possible topological superconductivity. However, whether or not the topological surface state is robust against impurities is not clear in this system. Here we report a detailed investigation on the lattice structure, electronic and magnetic properties, as well as the topological superconducting properties of SrxBi2Se3-ySy samples. It is found that the superconducting transition temperature keeps nearly unchanged in all samples, despite of a gradual decrease of the superconducting shielding volume fraction with increasing S doping content. Meanwhile, the Shubnikov-de Hass oscillation results of the SrxBi2Se3-ySy samples reveal that the topological surface states are destroyed in S doped samples, suggesting the topological character is degraded by nonmagnetic dopants.
ABSTRACT
Myoblasts are mononucleated precursors of myofibers; they persist in mature skeletal muscles for growth and regeneration post injury. During myotonic dystrophy type 1 (DM1), a complex autosomal-dominant neuromuscular disease, the differentiation of skeletal myoblasts into functional myotubes is impaired, resulting in muscle wasting and weakness. The mechanisms leading to this altered differentiation are not fully understood. Here, we demonstrate that the calcium- and voltage-dependent potassium channel, KCa1.1 (BK, Slo1, KCNMA1), regulates myoblast proliferation, migration, and fusion. We also show a loss of plasma membrane expression of the pore-forming α subunit of KCa1.1 in DM1 myoblasts. Inhibiting the function of KCa1.1 in healthy myoblasts induced an increase in cytosolic calcium levels and altered nuclear factor kappa B (NFκB) levels without affecting cell survival. In these normal cells, KCa1.1 block resulted in enhanced proliferation and decreased matrix metalloproteinase secretion, migration, and myotube fusion, phenotypes all observed in DM1 myoblasts and associated with disease pathogenesis. In contrast, introducing functional KCa1.1 α-subunits into DM1 myoblasts normalized their proliferation and rescued expression of the late myogenic marker Mef2. Our results identify KCa1.1 channels as crucial regulators of skeletal myogenesis and suggest these channels as novel therapeutic targets in DM1.
Subject(s)
Cell Differentiation , Cell Movement , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/metabolism , Myoblasts, Skeletal/cytology , Myoblasts, Skeletal/metabolism , Calcium/metabolism , Cell Fusion , Cell Membrane/metabolism , Cell Proliferation , Cells, Cultured , Humans , Intracellular Space/metabolism , Matrix Metalloproteinase 2/metabolism , Muscle Fibers, Skeletal/cytology , Muscle Fibers, Skeletal/metabolism , Myotonic Dystrophy/pathology , NF-kappa B/metabolismABSTRACT
OBJECTIVE: Fibroblast-like synoviocytes (FLS) participate in joint inflammation and damage in rheumatoid arthritis (RA) and its animal models. The purpose of this study was to define the importance of KCa1.1 (BK, Maxi-K, Slo1, KCNMA1) channel expression and function in FLS and to establish these channels as potential new targets for RA therapy. METHODS: We compared KCa1.1 expression levels in FLS from rats with pristane-induced arthritis (PIA) and in FLS from healthy rats. We then used ex vivo functional assays combined with small interfering RNA-induced knockdown, overexpression, and functional modulation of KCa1.1 in PIA FLS. Finally, we determined the effectiveness of modulating KCa1.1 in 2 rat models of RA, moderate PIA and severe collagen-induced arthritis (CIA). RESULTS: We found that PIA FLS expressed the KCa1.1 channel as their major potassium channel, as has been found in FLS from patients with RA. In contrast, FLS from healthy rats expressed fewer of these channels. Inhibiting the function or expression of KCa1.1 ex vivo reduced proliferation and invasive properties of, as well as protease production by, PIA FLS, whereas opening native KCa1.1 or overexpressing the channel enhanced the invasiveness of both FLS from rats with PIA and FLS from healthy rats. Treatment with a KCa1.1 channel blocker at the onset of clinical signs stopped disease progression in the PIA and CIA models, reduced joint and bone damage, and inhibited FLS invasiveness and proliferation. CONCLUSION: Our results demonstrate a critical role of KCa1.1 channels in the regulation of FLS invasiveness and suggest that KCa1.1 channels represent potential therapeutic targets in RA.
Subject(s)
Arthritis, Rheumatoid/pathology , Arthritis, Rheumatoid/prevention & control , Cell Movement/physiology , Fibroblasts/pathology , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/antagonists & inhibitors , Synovial Membrane/pathology , Animals , Arthritis, Experimental/pathology , Arthritis, Experimental/physiopathology , Arthritis, Rheumatoid/chemically induced , Cell Proliferation/physiology , Disease Models, Animal , Female , Fibroblasts/physiology , Indoles/pharmacology , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/drug effects , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/physiology , Matrix Metalloproteinase 2/physiology , Potassium Channel Blockers/pharmacology , Rats , Rats, Inbred Lew , Rats, Sprague-Dawley , Synovial Membrane/physiopathology , Terpenes/adverse effectsABSTRACT
Natural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune diseases such as multiple sclerosis. We demonstrate that human NK cells express the potassium channels Kv1.3 and KCa3.1. Expression of these channels does not vary with expression levels of maturation markers but varies between adherent and non-adherent NK cell subpopulations. Upon activation by mitogens or tumor cells, adherent NK (A-NK) cells preferentially up-regulate KCa3.1 and non-adherent (NA-NK) cells preferentially up-regulate Kv1.3. Consistent with this different phenotype, A-NK and NA-NK do not display the same sensitivity to the selective KCa3.1 blockers TRAM-34 and NS6180 and to the selective Kv1.3 blockers ShK-186 and PAP-1 in functional assays. Kv1.3 block inhibits the proliferation and degranulation of NA-NK cells with minimal effects on A-NK cells. In contrast, blocking KCa3.1 increases the degranulation and cytotoxicity of A-NK cells, but not of NA-NK cells. TRAM-34, however, does not affect their ability to form conjugates with target tumor cells, to migrate, or to express chemokine receptors. TRAM-34 and NS6180 also increase the proliferation of both A-NK and NA-NK cells. This results in a TRAM-34-induced increased ability of A-NK cells to reduce in vivo tumor growth. Taken together, our results suggest that targeting KCa3.1 on NK cells with selective blockers may be beneficial in cancer immunotherapy.
Subject(s)
Cytotoxicity, Immunologic , Intermediate-Conductance Calcium-Activated Potassium Channels/antagonists & inhibitors , Killer Cells, Natural/immunology , Animals , CX3C Chemokine Receptor 1 , Cell Adhesion/drug effects , Cell Degranulation/drug effects , Cell Movement/drug effects , Cytotoxicity, Immunologic/drug effects , Humans , Interleukin-12/pharmacology , Interleukin-15/pharmacology , Intermediate-Conductance Calcium-Activated Potassium Channels/metabolism , Ion Channel Gating/drug effects , K562 Cells , Killer Cells, Natural/drug effects , Killer Cells, Natural/physiology , Kv1.3 Potassium Channel/antagonists & inhibitors , Kv1.3 Potassium Channel/metabolism , Mice , Pancreatitis-Associated Proteins , Phenotype , Potassium Channel Blockers/pharmacology , Pyrazoles/metabolism , Receptors, Chemokine/metabolism , Recombinant Proteins/pharmacology , Up-Regulation/drug effectsABSTRACT
The Kv1.3 channel is a recognized target for pharmaceutical development to treat autoimmune diseases and organ rejection. ShK-186, a specific peptide inhibitor of Kv1.3, has shown promise in animal models of multiple sclerosis and rheumatoid arthritis. Here, we describe the pharmacokinetic-pharmacodynamic relationship for ShK-186 in rats and monkeys. The pharmacokinetic profile of ShK-186 was evaluated with a validated high-performance liquid chromatography-tandem mass spectrometry method to measure the peptide's concentration in plasma. These results were compared with single-photon emission computed tomography/computed tomography data collected with an ¹¹¹In-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugate of ShK-186 to assess whole-blood pharmacokinetic parameters as well as the peptide's absorption, distribution, and excretion. Analysis of these data support a model wherein ShK-186 is absorbed slowly from the injection site, resulting in blood concentrations above the Kv1.3 channel-blocking IC50 value for up to 7 days in monkeys. Pharmacodynamic studies on human peripheral blood mononuclear cells showed that brief exposure to ShK-186 resulted in sustained suppression of cytokine responses and may contribute to prolonged drug effects. In delayed-type hypersensitivity, chronic relapsing-remitting experimental autoimmune encephalomyelitis, and pristane-induced arthritis rat models, a single dose of ShK-186 every 2 to 5 days was as effective as daily administration. ShK-186's slow distribution from the injection site and its long residence time on the Kv1.3 channel contribute to the prolonged therapeutic effect of ShK-186 in animal models of autoimmune disease.
Subject(s)
Autoimmune Diseases/drug therapy , Kv1.3 Potassium Channel/antagonists & inhibitors , Proteins/pharmacology , T-Lymphocytes/drug effects , Absorption/drug effects , Absorption/immunology , Animals , Arthritis/drug therapy , Arthritis/immunology , Arthritis/metabolism , Autoimmune Diseases/immunology , Autoimmune Diseases/metabolism , Cytokines/immunology , Cytokines/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/metabolism , Female , Humans , Inhibitory Concentration 50 , Kv1.3 Potassium Channel/immunology , Kv1.3 Potassium Channel/metabolism , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Macaca fascicularis , Potassium Channel Blockers/immunology , Potassium Channel Blockers/pharmacokinetics , Potassium Channel Blockers/pharmacology , Proteins/pharmacokinetics , Rats , Rats, Sprague-Dawley , Saimiri , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Tissue Distribution/drug effects , Tissue Distribution/immunologyABSTRACT
Fibroblast-like synoviocytes (FLS) play important roles in the pathogenesis of rheumatoid arthritis (RA). Potassium channels have regulatory roles in many cell functions. We have identified the calcium- and voltage-gated KCa1.1 channel (BK, Maxi-K, Slo1, KCNMA1) as the major potassium channel expressed at the plasma membrane of FLS isolated from patients with RA (RA-FLS). We further show that blocking this channel perturbs the calcium homeostasis of the cells and inhibits the proliferation, production of VEGF, IL-8, and pro-MMP-2, and migration and invasion of RA-FLS. Our findings indicate a regulatory role of KCa1.1 channels in RA-FLS function and suggest this channel as a potential target for the treatment of RA.
Subject(s)
Cell Membrane/metabolism , Gene Expression Regulation , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/biosynthesis , Rheumatic Fever/metabolism , Synovial Fluid/metabolism , Synovial Membrane/metabolism , Adult , Aged , Aged, 80 and over , Calcium/metabolism , Cell Membrane/pathology , Cell Proliferation , Enzyme Precursors/biosynthesis , Female , Gelatinases/biosynthesis , HEK293 Cells , Homeostasis , Humans , Interleukin-8/biosynthesis , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/antagonists & inhibitors , Male , Middle Aged , Rheumatic Fever/pathology , Synovial Membrane/pathology , Vascular Endothelial Growth Factor A/biosynthesisABSTRACT
Matrix metalloproteinases (MMPs) are zinc-containing endopeptidases. They degrade proteins by cleavage of peptide bonds. More than twenty MMPs have been identified and are separated into six groups based on their structure and substrate specificity (collagenases, gelatinases, membrane type [MT-MMP], stromelysins, matrilysins, and others). MMPs play a critical role in cell invasion, cartilage degradation, tissue remodeling, wound healing, and embryogenesis. They therefore participate in both normal processes and in the pathogenesis of many diseases, such as rheumatoid arthritis, cancer, or chronic obstructive pulmonary disease. Here, we will focus on MMP-2 (gelatinase A, type IV collagenase), a widely expressed MMP. We will demonstrate how to detect MMP-2 in cell culture supernatants by zymography, a commonly used, simple, and yet very sensitive technique first described in 1980 by C. Heussen and E.B. Dowdle. This technique is semi-quantitative, it can therefore be used to determine MMP levels in test samples when known concentrations of recombinant MMP are loaded on the same gel. Solutions containing MMPs (e.g. cell culture supernatants, urine, or serum) are loaded onto a polyacrylamide gel containing sodium dodecyl sulfate (SDS; to linearize the proteins) and gelatin (substrate for MMP-2). The sample buffer is designed to increase sample viscosity (to facilitate gel loading), provide a tracking dye (bromophenol blue; to monitor sample migration), provide denaturing molecules (to linearize proteins), and control the pH of the sample. Proteins are then allowed to migrate under an electric current in a running buffer designed to provide a constant migration rate. The distance of migration is inversely correlated with the molecular weight of the protein (small proteins move faster through the gel than large proteins do and therefore migrate further down the gel). After migration, the gel is placed in a renaturing buffer to allow proteins to regain their tertiary structure, necessary for enzymatic activity. The gel is then placed in a developing buffer designed to allow the protease to digest its substrate. The developing buffer also contains p-aminophenylmercuric acetate (APMA) to activate the non-proteolytic pro-MMPs into active MMPs. The next step consists of staining the substrate (gelatin in our example). After washing the excess dye off the gel, areas of protease digestion appear as clear bands. The clearer the band, the more concentrated the protease it contains. Band staining intensity can then be determined by densitometry, using a software such as ImageJ, allowing for sample comparison.
Subject(s)
Electrophoresis, Polyacrylamide Gel/methods , Matrix Metalloproteinases/analysis , Acrylic Resins , Matrix Metalloproteinase 2/analysis , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinases/metabolism , Sodium Dodecyl SulfateABSTRACT
Hepcidin is an antimicrobial peptide and an iron-regulatory hormone that is conserved in fish, amphibians, and mammalians. Here we report the genomic and biochemical characterization of two amphibian hepcidins (tHEP1 and tHEP2) from the Western clawed frog (Xenopus tropicalis). Similar to fish and mammalian hepcidins, both tHEP1 and tHEP2 genes contain three exons and two introns. The predicted mature tHEP1 and tHEP2 hepcidins are a 25 amino acid peptide and a 24 amino acid peptide, respectively. Both tHEP1 and tHEP2 are strongly expressed in the liver and kidney, with detectable expression in the heart. In addition, tHEP2 is also moderately expressed in the stomach and testis. The expression of tHEP2 (but not tHEP1) in the liver is strongly induced by iron overloading, while the expression of tHEP1 (but not tHEP2) in the liver is significantly inhibited by corticosterone. Genomic analysis of the promoter regions of these two frog hepcidin genes indicates that transcription regulation factors NF-kappaB and C/EBPbeta may be involved in hepcidin regulation by iron. Hence, X. tropicalis is a useful model for the study of molecular evolution, transcriptional regulation, and structure-activity relationships of vertebrate hepcidins.
Subject(s)
Anti-Bacterial Agents/analysis , Antimicrobial Cationic Peptides/analysis , Xenopus/genetics , Amino Acid Sequence , Animals , Antimicrobial Cationic Peptides/genetics , Base Sequence , Exons , Gene Expression Regulation , Hepcidins , Introns , Iron/metabolism , Iron/physiology , Molecular Sequence DataABSTRACT
Impaired expression of alpha-defensin antimicrobial peptides and overproduction of the proinflammatory cytokine IL-1beta have been associated with inflammatory bowel disease. In this study, we examine the interactions between alpha-defensins and IL-1beta and the role of defensin deficiency in the pathogenesis of inflammatory bowel disease. It was found that matrix metalloproteinase-7-deficient (MMP-7(-/-)) mice, which produce procryptdins but not mature cryptdins (alpha-defensins) in the intestine, were more susceptible to dextran sulfate sodium-induced colitis. Furthermore, both baseline and dextran sulfate sodium-induced IL-1beta production in the intestine were significantly up-regulated in MMP-7(-/-) mice compared with that in control C57BL/6 mice. To elucidate the molecular mechanism for the increased IL-1beta production in defensin deficiency in vivo, we evaluated the effect of defensins on IL-1beta posttranslational processing and release. It was found that alpha-defensins, including mouse Paneth cell defensins cryptdin-3 and cryptdin-4, human neutrophil defensin HNP-1, and human Paneth cell defensin HD-5, blocked the release of IL-1beta from LPS-activated monocytes, whereas TNF-alpha expression and release were not affected. Unlike alpha-defensins, human beta-defensins and mouse procryptdins do not have any effect on IL-1beta processing and release. Thus, alpha-defensins may play an important role in intestinal homeostasis by controlling the production of IL-1beta.
Subject(s)
Defensins/metabolism , Homeostasis/physiology , Inflammatory Bowel Diseases/metabolism , Interleukin-1beta/metabolism , Intestinal Mucosa/metabolism , Amino Acid Sequence , Animals , Antiviral Agents/toxicity , Defensins/genetics , Dextran Sulfate/toxicity , Humans , Immunoprecipitation , Matrix Metalloproteinase 7/deficiency , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Monocytes , RNA Processing, Post-Transcriptional , Sequence Homology, Amino AcidABSTRACT
Hepcidin, originally identified as a 25 amino acid antimicrobial peptide made in the liver, is a key regulator of iron balance and recycling in humans and mice. Closely related hepcidin genes and peptides have also been identified in a number of fish species and in teleosts are thought to function as endogenous antibiotics involved in host defense against infection. Here we report the transcriptional regulation of hepcidin expression by infection and anemia in the channel catfish. Changes in hepcidin expression in catfish challenged with Edwardsiella ictaluri and in fish affected by channel catfish anemia (CCA) were measured by real time quantitative PCR. Hepcidin transcript levels in the livers were increased 4, 19, and 22-fold at 4, 24, and 48h following bacterial challenge, respectively. However, augmented hepcidin expression in the intestine and olfactory sac was detected only at 48h post-infection. Hepcidin transcript levels in the livers of catfish affected by CCA were less than 14% of that present in healthy counterparts. Hepatic hepcidin transcript levels correlated significantly with serum iron concentrations (r=0.54, p<0.05) and with the percent saturation of transferrin (r=0.63, p<0.05). Similar to mammalian hepcidins, channel catfish hepcidin is an iron-responsive gene and may also play important roles in innate host defense to infection and in iron homeostasis. Mammalian hepcidins may have evolved from an antimicrobial peptide and its structure and transcriptional regulatory mechanisms have been conserved throughout vertebrate evolution.
Subject(s)
Anemia/veterinary , Antimicrobial Cationic Peptides/metabolism , Edwardsiella ictaluri , Enterobacteriaceae Infections/veterinary , Fish Diseases/metabolism , Ictaluridae , Liver/metabolism , Amino Acid Sequence , Anemia/genetics , Anemia/immunology , Anemia/metabolism , Animals , Base Sequence , Enterobacteriaceae Infections/genetics , Enterobacteriaceae Infections/immunology , Enterobacteriaceae Infections/metabolism , Fish Diseases/genetics , Fish Diseases/immunology , Gene Expression Regulation , Hepcidins , Iron/blood , Molecular Sequence Data , Organ Specificity , Polymerase Chain Reaction , Species SpecificityABSTRACT
We report the biochemical and functional properties of a novel bovine beta-defensin (bBD-1). Cloned from bovine mammary papillary duct epithelia, the bBD-1 cDNA predicts a 69 amino acid propeptide that is much more similar to human beta-defensin-1 (hBD-1) than to other bovine defensins. The bBD-1 gene contains two exons and one 8.5 kb intron. Using RT-PCR, we detected the bBD-1 transcript in the teat mucosa, kidney, vagina, ovary, oviduct, and colon. A synthetic bBD-1 peptide demonstrates potent antibacterial activity against Escherichia coli. The widespread expression of bBD-1 mRNA indicates that bBD-1 may play an important role in the bovine host defense against infections.